Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for prevention of delirium and agitation in mechanically ventilated ICU patients
IRCT20190215042716N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in delirium and agitation comparing Escitalopram with Placebo (2 arms). Primary endpoints: Delirium and Agitation. Started Dec 2023; status: completed.
02
Drugs
escitalopram
03
Conditions
deliriumagitation
Beyond the preview
Go deeper on IRCT20190215042716N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190215042716N6.